These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1424751)

  • 1. Antigen processing and presentation in the eye: a review.
    Liversidge J; Forrester JV
    Curr Eye Res; 1992; 11 Suppl():49-58. PubMed ID: 1424751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation.
    Percopo CM; Hooks JJ; Shinohara T; Caspi R; Detrick B
    J Immunol; 1990 Dec; 145(12):4101-7. PubMed ID: 2147935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
    Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
    J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
    Laliotou B; Liversidge J; Forrester JV; Dick AD
    Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.
    Liversidge J; Dawson R; Dick AD; Forrester JV
    Immunology; 1998 Jun; 94(2):271-8. PubMed ID: 9741352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins.
    Wang M; Bai F; Pries M; Buus S; Prause JU; Nissen MH
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3939-45. PubMed ID: 16936108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen.
    Fling SP; Donoso LA; Gregerson DS
    J Immunol; 1991 Jul; 147(2):483-9. PubMed ID: 1712808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen/MHC class II/Ig dimers for study of uveitogenic T cells: IRBP p161-180 presented by both IA and IE molecules.
    Karabekian Z; Lytton SD; Silver PB; Sergeev YV; Schneck JP; Caspi RR
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3769-76. PubMed ID: 16186361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
    Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
    Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of retinal autoantigens and their peptides on the inhibition of experimental autoimmune uveitis.
    Dua HS; Abrams MS; Barrett JA; Donoso LA
    Eye (Lond); 1992; 6 ( Pt 5)():447-52. PubMed ID: 1286703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes.
    Merryman CF; Donoso LA; Zhang XM; Heber-Katz E; Gregerson DS
    J Immunol; 1991 Jan; 146(1):75-80. PubMed ID: 1701801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis.
    Caspi RR; Chan CC; Fujino Y; Oddo S; Najafian F; Bahmanyar S; Heremans H; Wilder RL; Wiggert B
    Curr Eye Res; 1992; 11 Suppl():81-6. PubMed ID: 1424754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresponsiveness to self-peptides of S-antigen in EAU: an overview of recent results.
    Gregerson DS; Fling SP; Donoso LA; Gold DP
    Curr Eye Res; 1992; 11 Suppl():67-74. PubMed ID: 1385044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by rat brain and retinal endothelial cells.
    Wang Y; Calder VL; Lightman SL; Greenwood J
    J Neuroimmunol; 1995 Sep; 61(2):231-9. PubMed ID: 7593559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritic cells and "dendritic" macrophages in the uveal tract.
    Forrester JV; McMenamin PG; Liversidge J; Lumsden L
    Adv Exp Med Biol; 1993; 329():599-604. PubMed ID: 8379432
    [No Abstract]   [Full Text] [Related]  

  • 20. Are accessory molecules implicated in activation of T cells at the blood-retinal barrier?
    Liversidge J; Forrester JV
    Curr Eye Res; 1990; 9 Suppl():131-4. PubMed ID: 2116956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.